| 摘要 |
Arylpyrazine compounds are provided, including arylpyrazines that can bind with high affiity and high selectivity to CRF1 receptors, including human CRF1 receptors. The invention thus includes methods for treatment of disorders and diseases associated with CRF1 receptors, including CNS-related disorders and diseases, particularly affective disorders and diseases, and acute and chronic neurological disorders and diseases. |
| 申请人 |
NEUROGEN CORPORATION;YOON, TAEYOUNG;GE, PING;HORVATH, RAYMOND, F.;DE LOMBAERT, STEPHANE;HODGETTS, KEVIN, J.;DOLLER, DARIO;ZHANG, CUNYU |
发明人 |
YOON, TAEYOUNG;GE, PING;HORVATH, RAYMOND, F.;DE LOMBAERT, STEPHANE;HODGETTS, KEVIN, J.;DOLLER, DARIO;ZHANG, CUNYU |
